Botanikind settles in Basel
The internationally active Swiss company Botanikind has settled in Basel and established Botanikind AG there. It provides natural ingredients for food and drink production.
Botanikind is pooling its European activities in its newly established headquarters in Basel. Botanikind AG was founded for this purpose will additionally coordinate global commercial activities and develop new innovations from its location in Basel. Botanikind was supported in settling by Basel Area Business & Innovation.
Botanikind has its operating headquarters in Shanghai and has established a vertically integrated supply chain in China. This means natural ingredients can be obtained directly from farmers for the food, drink and supplement industries. In doing so the company ensures quality and transparency between producers and consumers. The direct, simple supply chain additionally lowers costs. In China, the company sources from a broad range of natural raw materials and benefits from modern technologies.
Botanikind is proactively pursuing a decentralized structure in order to be as close to its customers as possible. The company sees Basel as the ideal location for its European headquarters as it is situated centrally and has great innovation potential due to the life sciences companies that are resident there. A team will now be established in Basel to make and implement strategic decisions for the European market. Furthermore, the company plans to open its own laboratory in Basel in the coming year. The proximity to life sciences companies is additionally important to Botanikind because the products it markets can also be used in supplements with health benefits.
Share this article
You may also be interested in
Evolva launches new line for manufacturers of personal care products
Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...Read More
Record figure for startups in the Basel Area
Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...Read More
Noema Pharma raises 103 million Swiss francs from investors
Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....Read More
Why CDMO companies choose the Basel Area as their location
Originally, this article was published by the US magazine Outsourced Pharma under the title "Why Location Matters". The article highlights...Read More
Basel still the most attractive small city for business in Europe
As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...Read More
Ariceum Therapeutics establishes subsidiary in Basel
The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...Read More